Standard BioTools
LAB
119 hedge funds and large institutions have $387M invested in Standard BioTools in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 39 reducing their positions, and 12 closing their positions.
202% more call options, than puts
Call options by funds: $4.08M | Put options by funds: $1.35M
58% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 12
9% more capital invested
Capital invested by funds: $354M → $387M (+$32.4M)
5% more funds holding
Funds holding: 113 → 119 (+6)
0.16% more ownership
Funds ownership: 76.82% → 76.98% (+0.16%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
18% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.63M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$2.1M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.92M |
| 4 |
SAM
Silverback Asset Management
Chapel Hill,
North Carolina
|
+$1.88M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$1.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.49M |
| 2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.07M |
| 3 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
-$887K |
| 4 |
Jennison Associates
New York
|
-$830K |
| 5 |
CAM
Connacht Asset Management
New York
|
-$794K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NFSG
126
Newbridge Financial Services Group
Boca Raton,
Florida
| – | -$3K | -500 | Closed |
|
127
US Bancorp
Minneapolis,
Minnesota
| – | -$3K | -500 | Closed |
|
|
DFCM
128
Dark Forest Capital Management
San Juan,
Puerto Rico
| – | -$2.18K | -331 | -82% |
|
|
TFS
129
TrustCore Financial Services
Brentwood,
Tennessee
| – | -$1K | -112 | Closed |
|
130
Fidelity Investments
Boston,
Massachusetts
| – | +$33 | +5 | New |
|
LAB Hedge Fund Activity: Q3 2021 in Review
119 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2021, worth a combined $387M — up 9.1% from $354M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new LAB positions and 12 closed out — a net gain of 7 holders — while 32 added to existing stakes and 39 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $2.63M. The largest seller was Millennium Management, cutting an estimated $3.49M.
- 119 institutional investors held Standard BioTools (LAB) as of Q3 2021, up from 113 in Q2 2021.
- Funds reported $387M of Standard BioTools stock for Q3 2021, up 9.1% quarter-over-quarter.
- 19 funds opened new Standard BioTools positions in Q3 2021 and 12 closed out, a net change of +7 holders.
- The largest Standard BioTools buyer in Q3 2021 was Adage Capital Partners, an estimated $2.63M added.
- The largest Standard BioTools seller in Q3 2021 was Millennium Management, an estimated $3.49M sold.
Based on aggregated 13F filings for Q3 2021.